ARWR
Price
$32.23
Change
+$0.58 (+1.83%)
Updated
Sep 26, 02:46 PM (EDT)
Capitalization
4.38B
66 days until earnings call
IPSC
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Sep 26, 01:10 PM (EDT)
Capitalization
42.13M
41 days until earnings call
Interact to see
Advertisement

ARWR vs IPSC

Header iconARWR vs IPSC Comparison
Open Charts ARWR vs IPSCBanner chart's image
Arrowhead Pharmaceuticals
Price$32.23
Change+$0.58 (+1.83%)
Volume$300
Capitalization4.38B
Century Therapeutics
Price$0.49
Change-$0.00 (-0.00%)
Volume$200
Capitalization42.13M
ARWR vs IPSC Comparison Chart in %
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. IPSC commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a StrongBuy and IPSC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ARWR: $31.66 vs. IPSC: $0.49)
Brand notoriety: ARWR: Notable vs. IPSC: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 90% vs. IPSC: 59%
Market capitalization -- ARWR: $4.38B vs. IPSC: $42.13M
ARWR [@Biotechnology] is valued at $4.38B. IPSC’s [@Biotechnology] market capitalization is $42.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, ARWR is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 4 bullish TA indicator(s).

  • ARWR’s TA Score: 3 bullish, 3 bearish.
  • IPSC’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than ARWR.

Price Growth

ARWR (@Biotechnology) experienced а +0.48% price change this week, while IPSC (@Biotechnology) price change was -3.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.35%. For the same industry, the average monthly price growth was +8.65%, and the average quarterly price growth was +50.95%.

Reported Earning Dates

ARWR is expected to report earnings on Dec 01, 2025.

IPSC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+3.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($4.38B) has a higher market cap than IPSC($42.1M). ARWR YTD gains are higher at: 68.404 vs. IPSC (-51.713). IPSC has higher annual earnings (EBITDA): -6.16M vs. ARWR (-52.51M). ARWR has more cash in the bank: 900M vs. IPSC (156M). IPSC has less debt than ARWR: IPSC (51.5M) vs ARWR (353M). ARWR has higher revenues than IPSC: ARWR (573M) vs IPSC (114M).
ARWRIPSCARWR / IPSC
Capitalization4.38B42.1M10,397%
EBITDA-52.51M-6.16M853%
Gain YTD68.404-51.713-132%
P/E RatioN/AN/A-
Revenue573M114M503%
Total Cash900M156M577%
Total Debt353M51.5M685%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRIPSC
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNS58.610.50
+0.86%
Varonis Systems
UBER97.60-0.18
-0.18%
Uber Technologies
EH18.59-0.08
-0.43%
EHang Holdings Limited
ACCS10.74-0.26
-2.36%
ACCESS Newswire Inc
LFMD6.22-0.18
-2.81%
LifeMD

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+0.66%
CRSP - IPSC
55%
Loosely correlated
-1.20%
CABA - IPSC
52%
Loosely correlated
-6.48%
IMNM - IPSC
51%
Loosely correlated
-9.33%
ARWR - IPSC
51%
Loosely correlated
-3.56%
FATE - IPSC
50%
Loosely correlated
-3.88%
More